Erste Group lifts Amgen stock rating to Buy on strong margins

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, …

CouponFollow Extension

0%
OFF

Strong Buy Rating For Amgen Amidst Impressive Growth And …

2 weeks from now

Oct 30, 2024 · These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks , Werber is a 5-star analyst with an average return of 14.0% and …

businessinsider.com

$380.00
OFF

Buy Rating For Amgen: Strong Growth Prospects Driven By …

2 weeks from now

Oct 15, 2024 · In another report released yesterday, Jefferies also maintained a Buy rating on the stock with a $380.00 price target. See Insiders’ Hot Stocks on TipRanks >>

businessinsider.com

$349
OFF

What Analysts Are Saying About Amgen Stock - Nasdaq

2 weeks from now

Nov 14, 2024 · Analysts have set 12-month price targets for Amgen, revealing an average target of $349.0, a high estimate of $405.00, and a low estimate of $215.00.

nasdaq.com

100%
OFF

Amgen Shares Keep Buy Rating As Analyst Updates Model Ahead Of …

2 weeks from now

Oct 21, 2024 · ⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocks Unlock stocks Get 100% ad-free experience Amgen shares keep buy rating as …

investing.com

$362.00
OFF

Amgen’s Strategic Shift And Strong Pipeline Drive Buy Rating

2 weeks from now

Jan 14, 2025 · Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Amgen (AMGN – Research Report), retaining the price target of $362.00. Discover outperforming …

businessinsider.com

7%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024 · While Amgen's (NASDAQ: AMGN) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

yahoo.com

$310.63
OFF

Amgen (NASDAQ:AMGN) Stock, Analyst Ratings, Price Targets, …

2 weeks from now

Amgen Inc has a consensus price target of $310.63 based on the ratings of 33 analysts. The high is $405 issued by Cantor Fitzgerald on October 22, 2024 . The low is $200 issued by Credit …

benzinga.com

$383.00
OFF

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024 · TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00. Yaron Wer...

businessinsider.com

FAQs about Erste Group lifts Amgen stock rating to Buy on strong margins Coupon?

Why did Erste Group Upgrade Amgen shares from hold to buy?

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, which includes a higher operating margin and impressive 56% return on equity. ...

Should you buy Amgen (Amgen) stock?

These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks, Werber is a 5-star analyst with an average return of 14.0% and a 57.14% success rate. Werber covers the Healthcare sector, focusing on stocks such as Amgen, BioNTech SE, and Exelixis. ...

Is Amgen (Amgen) overvalued?

The two-model average is ~$299.37, indicating that Amgen is overvalued at the current price. However, Wall Street analysts are somewhat less bullish, with an average price target of $313.66, 2.5% higher than the current value and more than our two-model average. ...

Is Amgen Inc (AMGN) undervalued?

Valuation metrics show that Amgen Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AMGN, demonstrate its potential to outperform the market. It currently has a Growth Score of C. ...

Why has Yaron Werber rated Amgen (Amgen) a buy?

Yaron Werber has given his Buy rating due to a combination of factors that indicate strong future growth for Amgen. The company’s performance in the third quarter was impressive, with earnings per share exceeding expectations due to reduced operational expenses and tax rates. ...

Why is Amgen a leveraged company?

Amgen is leveraged because of the Horizon Therapeutics acquisition. It carries $3,550 million of short-term and current long-term debt and $56,549 million of long-term debt. It is offset by about $11,973 million in cash and equivalents. Hence, the leverage ratio is ~3.74X, down from 4.39X. ...